A novel germline mutation in Peroxisome Proliferator-Activated Receptor γ gene associated with large intestine polyp formation and dyslipidemia (192 visite)
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2010; 1802(6): 572-581.
Tipo di articolo: Journal Article,
Impact factor: 2.773, Impact factor a 5 anni: 2.751
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-77952240564&partnerID=40&md5=f0a185472554530c6ce54fec0f6a1265
Parole chiave: Colorectal Cancer, Dyslipidemia, Loss-Of-Function Mutation, Peroxisome Proliferator-Activated Receptor, High Density Lipoprotein Cholesterol, Insulin, Low Density Lipoprotein Cholesterol, Peroxisome Proliferator Activated Receptor Gamma, Triacylglycerol, Adult, Aged, Amino Acid Substitution, Article, Cancer Localization, Cell Proliferation, Cholesterol Blood Level, Clinical Article, Colon Carcinogenesis, Colon Polyp, Colonoscopy, Controlled Study, Female, Gene Mutation, Genetic Association, Germ Line, Glucose Blood Level, Histopathology, Human, Human Cell, Human Tissue, Hypertension, In Vitro Study, In Vivo Study, Insulin Blood Level, Ligand Binding, Lipid Metabolism, Liver Metastasis, Loss Of Function Mutation, Non Insulin Dependent Diabetes Mellitus, Nucleotide Sequence, Obesity, Priority Journal, Protein Expression, Protein Function, Triacylglycerol Blood Level, Wild Type, Adenocarcinoma, Adolescent, 80 And Over, Animals, Base Sequence, Binding Sites, Cercopithecus Aethiops, Colonic Neoplasms, Cos Cells, Dna Primers, Germ-Line Mutation, Intestinal Polyps, Loss Of Heterozygosity, Middle Aged, Models, Molecular, Nih 3t3 Cells, Pedigree, Ppar Gamma, Recombinant Proteins, Transfection, Young Adult,
Affiliazioni:
*** IBB - CNR ***
Department of Biological and Environmental Sciences, University of Sannio, Via Port'Arsa, 11, 82100 Benevento, Italy
Institute of Genetics and Biophysics, A. Buzzati-Traverso CNR, Via P. Castellino, 113, 80131 Napoli, Italy
Department of Biochemistry and Medical Biotechnologies, University of Naples Federico II, Via S. Pansini, 5, 80131 Napoli, Italy
Fatebenefratelli Hospital, Division of Medical Oncology, Viale Principe di Napoli, 82100 Benevento, Italy
Department of Chemistry, University of Naples Federico II, Monte S. Angelo, 80100 Napoli, Italy
Riferimenti:
Francis, G.A., Fayard, E., Picard, F., Auwerx, J., Nuclear receptors and the control of metabolism (2003) Ann. Rev. Physiol., 65, pp. 261-31
Spiegelman, B.M., PPARγ: adipogenic regulator and thiazolidinedione receptor (1998) Diabetes, 47, pp. 507-514
Feige, J.N., Gelman, L., Michalik, L., Desvergne, B., Wahli, W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions (2006) Prog. Lipid Res., 45, pp. 120-159
Willson, T.M., Lambert, M.H., Kliewer, S.A., Peroxisome proliferator-activated receptor γ and metabolic disease (2001) Annu. Rev. Biochem., 70, pp. 341-367
Knouff, C., Auwerx, J., Peroxisome proliferator-activated receptor-γ calls for activation in moderation: lessons from genetics and pharmacology (2004) Endocr. Rev., 25, pp. 899-918
Sarraf, P., Mueller, E., Smith, W.M., Wright, H.M., Kum, J.B., Aaltonen, L.A., de la Chapelle, A., Eng, C., Loss-of-function mutations in PPARγ associated with human colon cancer (1999) Mol Cell, 3, pp. 799-804
Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., Kahn, C.R., Obesity associated with a mutation in a genetic regulator of adipocyte differentiation (1998) N. Engl. J. Med., 339, pp. 953-959
Grommes, C., Landreth, G., Heneka, M.T., Antineoplastic effects of peroxisome proliferator activated receptor γ agonists (2004) Lancet Oncol., 7, pp. 419-429
Sabatino, L., Casamassimi, A., Peluso, G., Barone, M.V., Capaccio, D., Migliore, C., Monelli, P., Colantuoni, V., A novel peroxisome proliferator-activated receptor γ isoform with dominant negative activity generated by alternative splicing (2005) J. Biol. Chem., 280, pp. 26517-26525
Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., O'Rahilly, S., Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension (1999) Nature, 402, pp. 880-883
Savage, D.B., Tan, G.D., Acerini, C.L., Jebb, S.A., Agostini, M., Gurnell, M., Williams, R.L., O'Rahilly, S., Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor γ (2003) Diabetes, 52, pp. 910-917
Peverali, F.A., Ramqvist, T., Saffrich, R., Pepperkok, R., Barone, M.V., Philipson, L., Regulation of G1 progression by E2A and Id helix-loop-helix proteins (1994) EMBO J., 13, pp. 4291-4301
Barone, M.V., Courtneidge, S.A., Myc but not Fos rescue of PDGF signaling block caused by kinase-inactive Src (1995) Nature, 378, pp. 509-512
Pancione, M., Forte, N., Sabatino, L., Tomaselli, E., Parente, D., Febbraro, A., Colantuoni, V., Reduced γ-catenin and peroxisome proliferator-activated receptor γ expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome (2009) Hum. Pathol., 40, pp. 714-725
Yeh, J.J., Marsh, D.J., Zedenius, J., Dwight, T., Delbridge, L., Robinson, B.G., Eng, C., Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways (1999) Genes Chromosomes Cancer, 26, pp. 322-328
Kinzler, K.W., Vogelstein, B., Lessons from hereditary colorectal cancer (1996) Cell, 87, pp. 159-170
Gupta, R.A., Sarraf, P., Mueller, E., Brockman, J.A., Prusakiewicz, J.J., Eng, C., Willson, T.M., DuBois, R.N., Peroxisome proliferator-activated receptor γ mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms (2003) J. Biol. Chem., 278, pp. 22669-22677
Girnun, G.D., Smith, W.M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Spiegelman, B.M., APC-dependent suppression of colon carcinogenesis by PPARγ (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 13771-13776
Teresi, R.E., Shaiu, C.W., Chen, C.S., Chatterjee, V.K., Waite, K.A., Eng, C., Increased PTEN expression due to transcriptional activation of PPARγ by lovastatin and rosiglitazone (2006) Int. J. Cancer, 118, pp. 2390-2398
Annicotte, J.S., Iankova, I., Miard, S., Fritz, V., Sarruf, D., Abella, A., Berthe, M.L., Iborra, F., Peroxisome proliferator-activated receptor γ regulates E-cadherin expression and inhibits growth and invasion of prostate cancer (2006) Mol. Cell. Biol., 26, pp. 7561-7574
Wang, D., Dubois, R.N., Peroxisome proliferator-activated receptors and progression of colorectal cancer (2008) PPAR Res, p. 931074
Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., Rose, D.W., Glass, C.K., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPARγ (2005) Nature, 437, pp. 759-763
Iatropoulos, M.J., Williams, G.M., Proliferation markers (1996) Exp. Toxicol. Pathol., 48, pp. 175-181
Platt, A.M., Mowat, A.M., Mucosal macrophages and the regulation of immune responses in the intestine (2008) Immunol. Lett., 119, pp. 22-31
Mori, M., Shimono, R., Adachi, Y., Matsuda, H., Kuwano, H., Sugimachi, K., Ikeda, M., Saku, M., Transitional mucosa in human colorectal lesions (1990) Dis. Colon Rectum, 33, pp. 498-501
Gampe, R.T., Montana, V.G., Lambert, M.H., Miller, A.B., Bledsoe, R.K., Milburn, M.V., Kliever, S.A., Xu, E.H., Asymmetry in the PPARγ /RXRγ crystal structure reveals the molecular basis of heterodimerization among nuclear receptors (2000) Mol. Cell, 5, pp. 545-555
Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., Berkenstam, A., Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ (1998) J. Biol. Chem., 273, pp. 31108-31112
Petersen, M.T., Jonson, P.H., Petersen, S.B., Amino acid neighbours and detailed conformational analysis of cysteines in proteins (1999) Protein Eng., 12, pp. 535-548
Kraulis, P.J., MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures (1991) J. Appl. Crystallogr., 24, pp. 946-950
Rogler, G., Significance of anti-inflammatory effects of PPARγ agonists? (2006) Gut, 55, pp. 1067-1069
Alberici, P., Gaspar, C., Franken, P., Gorski, M.M., de Vries, I., Scott, R.J., Ristimäki, A., Fodde, R., Smad4 haploinsufficiency: a matter of dosage (2008) Pathogenetics, 1, pp. 2-12
Eng, C., Schneider, K., Fraumeni, J.F., Li, F.P., Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome (1997) Cancer Epidemiol. Biomarkers Prev., 6, pp. 379-383
Russell-Swetek, A., West, A.N., Mintern, J.E., Jenkins, J., Rodriguez-Galindo, C., Ribeiro, R., Zambetti, G.P., Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma (2008) J. Med. Genet., 45, pp. 603-606
Ikezoe, T., Miller, C.W., Kawano, S., Heaney, A., Williamson, E.A., Hisatake, J., Green, E., Koeffler, H.P., Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies (2001) Cancer Res., 61, pp. 5307-5310
Tsai, Y.S., Kim, H.J., Takahashi, N., Kim, H.S., Hagaman, J.R., Kim, J.K., Maeda, N., Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ (2004) J. Clin. Invest, 114, pp. 163-175
Meredith, D., Panchatcharam, M., Miriyala, S., Tsai, Y.S., Morris, A.J., Maeda, N., Stouffer, G.A., Smyth, S.S., Dominant-negative loss of PPARγ function enhances smooth muscle cell proliferation, migration, and vascular remodeling (2009) Arterioscler. Thromb. Vasc. Biol., 29, pp. 465-471
Francis, G. A., Fayard, E., Picard, F., Auwerx, J., Nuclear receptors and the control of metabolism (2003) Ann. Rev. Physiol., 65, pp. 261-31
Spiegelman, B. M., PPAR: adipogenic regulator and thiazolidinedione receptor (1998) Diabetes, 47, pp. 507-514
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., Wahli, W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions (2006) Prog. Lipid Res., 45, pp. 120-159
Willson, T. M., Lambert, M. H., Kliewer, S. A., Peroxisome proliferator-activated receptor and metabolic disease (2001) Annu. Rev. Biochem., 70, pp. 341-367
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., O'Rahilly, S., Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor (2003) Diabetes, 52, pp. 910-917
Peverali, F. A., Ramqvist, T., Saffrich, R., Pepperkok, R., Barone, M. V., Philipson, L., Regulation of G1 progression by E2A and Id helix-loop-helix proteins (1994) EMBO J., 13, pp. 4291-4301
Barone, M. V., Courtneidge, S. A., Myc but not Fos rescue of PDGF signaling block caused by kinase-inactive Src (1995) Nature, 378, pp. 509-512
Yeh, J. J., Marsh, D. J., Zedenius, J., Dwight, T., Delbridge, L., Robinson, B. G., Eng, C., Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways (1999) Genes Chromosomes Cancer, 26, pp. 322-328
Kinzler, K. W., Vogelstein, B., Lessons from hereditary colorectal cancer (1996) Cell, 87, pp. 159-170
Gupta, R. A., Sarraf, P., Mueller, E., Brockman, J. A., Prusakiewicz, J. J., Eng, C., Willson, T. M., DuBois, R. N., Peroxisome proliferator-activated receptor mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms (2003) J. Biol. Chem., 278, pp. 22669-22677
Girnun, G. D., Smith, W. M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Spiegelman, B. M., APC-dependent suppression of colon carcinogenesis by PPAR (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 13771-13776
Teresi, R. E., Shaiu, C. W., Chen, C. S., Chatterjee, V. K., Waite, K. A., Eng, C., Increased PTEN expression due to transcriptional activation of PPAR by lovastatin and rosiglitazone (2006) Int. J. Cancer, 118, pp. 2390-2398
Annicotte, J. S., Iankova, I., Miard, S., Fritz, V., Sarruf, D., Abella, A., Berthe, M. L., Iborra, F., Peroxisome proliferator-activated receptor regulates E-cadherin expression and inhibits growth and invasion of prostate cancer (2006) Mol. Cell. Biol., 26, pp. 7561-7574
Iatropoulos, M. J., Williams, G. M., Proliferation markers (1996) Exp. Toxicol. Pathol., 48, pp. 175-181
Platt, A. M., Mowat, A. M., Mucosal macrophages and the regulation of immune responses in the intestine (2008) Immunol. Lett., 119, pp. 22-31
Gampe, R. T., Montana, V. G., Lambert, M. H., Miller, A. B., Bledsoe, R. K., Milburn, M. V., Kliever, S. A., Xu, E. H., Asymmetry in the PPAR /RXR crystal structure reveals the molecular basis of heterodimerization among nuclear receptors (2000) Mol. Cell, 5, pp. 545-555
Petersen, M. T., Jonson, P. H., Petersen, S. B., Amino acid neighbours and detailed conformational analysis of cysteines in proteins (1999) Protein Eng., 12, pp. 535-548
Kraulis, P. J., MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures (1991) J. Appl. Crystallogr., 24, pp. 946-950
Tsai, Y. S., Kim, H. J., Takahashi, N., Kim, H. S., Hagaman, J. R., Kim, J. K., Maeda, N., Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPAR (2004) J. Clin. Invest, 114, pp. 163-175
Bba-Gen Subjects (ISSN: 0925-4439, 0006-3002, 1570-9639), 2010; 1802(6): 572-581.
Tipo di articolo: Journal Article,
Impact factor: 2.773, Impact factor a 5 anni: 2.751
Url: http://www.scopus.com/inward/record.url?eid=2-s2.0-77952240564&partnerID=40&md5=f0a185472554530c6ce54fec0f6a1265
Parole chiave: Colorectal Cancer, Dyslipidemia, Loss-Of-Function Mutation, Peroxisome Proliferator-Activated Receptor, High Density Lipoprotein Cholesterol, Insulin, Low Density Lipoprotein Cholesterol, Peroxisome Proliferator Activated Receptor Gamma, Triacylglycerol, Adult, Aged, Amino Acid Substitution, Article, Cancer Localization, Cell Proliferation, Cholesterol Blood Level, Clinical Article, Colon Carcinogenesis, Colon Polyp, Colonoscopy, Controlled Study, Female, Gene Mutation, Genetic Association, Germ Line, Glucose Blood Level, Histopathology, Human, Human Cell, Human Tissue, Hypertension, In Vitro Study, In Vivo Study, Insulin Blood Level, Ligand Binding, Lipid Metabolism, Liver Metastasis, Loss Of Function Mutation, Non Insulin Dependent Diabetes Mellitus, Nucleotide Sequence, Obesity, Priority Journal, Protein Expression, Protein Function, Triacylglycerol Blood Level, Wild Type, Adenocarcinoma, Adolescent, 80 And Over, Animals, Base Sequence, Binding Sites, Cercopithecus Aethiops, Colonic Neoplasms, Cos Cells, Dna Primers, Germ-Line Mutation, Intestinal Polyps, Loss Of Heterozygosity, Middle Aged, Models, Molecular, Nih 3t3 Cells, Pedigree, Ppar Gamma, Recombinant Proteins, Transfection, Young Adult,
Affiliazioni:
*** IBB - CNR ***
Department of Biological and Environmental Sciences, University of Sannio, Via Port'Arsa, 11, 82100 Benevento, Italy
Institute of Genetics and Biophysics, A. Buzzati-Traverso CNR, Via P. Castellino, 113, 80131 Napoli, Italy
Department of Biochemistry and Medical Biotechnologies, University of Naples Federico II, Via S. Pansini, 5, 80131 Napoli, Italy
Fatebenefratelli Hospital, Division of Medical Oncology, Viale Principe di Napoli, 82100 Benevento, Italy
Department of Chemistry, University of Naples Federico II, Monte S. Angelo, 80100 Napoli, Italy
Riferimenti:
Francis, G.A., Fayard, E., Picard, F., Auwerx, J., Nuclear receptors and the control of metabolism (2003) Ann. Rev. Physiol., 65, pp. 261-31
Spiegelman, B.M., PPARγ: adipogenic regulator and thiazolidinedione receptor (1998) Diabetes, 47, pp. 507-514
Feige, J.N., Gelman, L., Michalik, L., Desvergne, B., Wahli, W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions (2006) Prog. Lipid Res., 45, pp. 120-159
Willson, T.M., Lambert, M.H., Kliewer, S.A., Peroxisome proliferator-activated receptor γ and metabolic disease (2001) Annu. Rev. Biochem., 70, pp. 341-367
Knouff, C., Auwerx, J., Peroxisome proliferator-activated receptor-γ calls for activation in moderation: lessons from genetics and pharmacology (2004) Endocr. Rev., 25, pp. 899-918
Sarraf, P., Mueller, E., Smith, W.M., Wright, H.M., Kum, J.B., Aaltonen, L.A., de la Chapelle, A., Eng, C., Loss-of-function mutations in PPARγ associated with human colon cancer (1999) Mol Cell, 3, pp. 799-804
Ristow, M., Muller-Wieland, D., Pfeiffer, A., Krone, W., Kahn, C.R., Obesity associated with a mutation in a genetic regulator of adipocyte differentiation (1998) N. Engl. J. Med., 339, pp. 953-959
Grommes, C., Landreth, G., Heneka, M.T., Antineoplastic effects of peroxisome proliferator activated receptor γ agonists (2004) Lancet Oncol., 7, pp. 419-429
Sabatino, L., Casamassimi, A., Peluso, G., Barone, M.V., Capaccio, D., Migliore, C., Monelli, P., Colantuoni, V., A novel peroxisome proliferator-activated receptor γ isoform with dominant negative activity generated by alternative splicing (2005) J. Biol. Chem., 280, pp. 26517-26525
Barroso, I., Gurnell, M., Crowley, V.E., Agostini, M., Schwabe, J.W., Soos, M.A., Maslen, G.L., O'Rahilly, S., Dominant negative mutations in human PPARγ associated with severe insulin resistance, diabetes mellitus and hypertension (1999) Nature, 402, pp. 880-883
Savage, D.B., Tan, G.D., Acerini, C.L., Jebb, S.A., Agostini, M., Gurnell, M., Williams, R.L., O'Rahilly, S., Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor γ (2003) Diabetes, 52, pp. 910-917
Peverali, F.A., Ramqvist, T., Saffrich, R., Pepperkok, R., Barone, M.V., Philipson, L., Regulation of G1 progression by E2A and Id helix-loop-helix proteins (1994) EMBO J., 13, pp. 4291-4301
Barone, M.V., Courtneidge, S.A., Myc but not Fos rescue of PDGF signaling block caused by kinase-inactive Src (1995) Nature, 378, pp. 509-512
Pancione, M., Forte, N., Sabatino, L., Tomaselli, E., Parente, D., Febbraro, A., Colantuoni, V., Reduced γ-catenin and peroxisome proliferator-activated receptor γ expression levels are associated with colorectal cancer metastatic progression: correlation with tumor-associated macrophages, cyclooxygenase 2, and patient outcome (2009) Hum. Pathol., 40, pp. 714-725
Yeh, J.J., Marsh, D.J., Zedenius, J., Dwight, T., Delbridge, L., Robinson, B.G., Eng, C., Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways (1999) Genes Chromosomes Cancer, 26, pp. 322-328
Kinzler, K.W., Vogelstein, B., Lessons from hereditary colorectal cancer (1996) Cell, 87, pp. 159-170
Gupta, R.A., Sarraf, P., Mueller, E., Brockman, J.A., Prusakiewicz, J.J., Eng, C., Willson, T.M., DuBois, R.N., Peroxisome proliferator-activated receptor γ mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms (2003) J. Biol. Chem., 278, pp. 22669-22677
Girnun, G.D., Smith, W.M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Spiegelman, B.M., APC-dependent suppression of colon carcinogenesis by PPARγ (2002) Proc. Natl. Acad. Sci. U.S.A., 99, pp. 13771-13776
Teresi, R.E., Shaiu, C.W., Chen, C.S., Chatterjee, V.K., Waite, K.A., Eng, C., Increased PTEN expression due to transcriptional activation of PPARγ by lovastatin and rosiglitazone (2006) Int. J. Cancer, 118, pp. 2390-2398
Annicotte, J.S., Iankova, I., Miard, S., Fritz, V., Sarruf, D., Abella, A., Berthe, M.L., Iborra, F., Peroxisome proliferator-activated receptor γ regulates E-cadherin expression and inhibits growth and invasion of prostate cancer (2006) Mol. Cell. Biol., 26, pp. 7561-7574
Wang, D., Dubois, R.N., Peroxisome proliferator-activated receptors and progression of colorectal cancer (2008) PPAR Res, p. 931074
Pascual, G., Fong, A.L., Ogawa, S., Gamliel, A., Li, A.C., Perissi, V., Rose, D.W., Glass, C.K., A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPARγ (2005) Nature, 437, pp. 759-763
Iatropoulos, M.J., Williams, G.M., Proliferation markers (1996) Exp. Toxicol. Pathol., 48, pp. 175-181
Platt, A.M., Mowat, A.M., Mucosal macrophages and the regulation of immune responses in the intestine (2008) Immunol. Lett., 119, pp. 22-31
Mori, M., Shimono, R., Adachi, Y., Matsuda, H., Kuwano, H., Sugimachi, K., Ikeda, M., Saku, M., Transitional mucosa in human colorectal lesions (1990) Dis. Colon Rectum, 33, pp. 498-501
Gampe, R.T., Montana, V.G., Lambert, M.H., Miller, A.B., Bledsoe, R.K., Milburn, M.V., Kliever, S.A., Xu, E.H., Asymmetry in the PPARγ /RXRγ crystal structure reveals the molecular basis of heterodimerization among nuclear receptors (2000) Mol. Cell, 5, pp. 545-555
Uppenberg, J., Svensson, C., Jaki, M., Bertilsson, G., Jendeberg, L., Berkenstam, A., Crystal structure of the ligand binding domain of the human nuclear receptor PPARγ (1998) J. Biol. Chem., 273, pp. 31108-31112
Petersen, M.T., Jonson, P.H., Petersen, S.B., Amino acid neighbours and detailed conformational analysis of cysteines in proteins (1999) Protein Eng., 12, pp. 535-548
Kraulis, P.J., MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures (1991) J. Appl. Crystallogr., 24, pp. 946-950
Rogler, G., Significance of anti-inflammatory effects of PPARγ agonists? (2006) Gut, 55, pp. 1067-1069
Alberici, P., Gaspar, C., Franken, P., Gorski, M.M., de Vries, I., Scott, R.J., Ristimäki, A., Fodde, R., Smad4 haploinsufficiency: a matter of dosage (2008) Pathogenetics, 1, pp. 2-12
Eng, C., Schneider, K., Fraumeni, J.F., Li, F.P., Third international workshop on collaborative interdisciplinary studies of p53 and other predisposing genes in Li-Fraumeni syndrome (1997) Cancer Epidemiol. Biomarkers Prev., 6, pp. 379-383
Russell-Swetek, A., West, A.N., Mintern, J.E., Jenkins, J., Rodriguez-Galindo, C., Ribeiro, R., Zambetti, G.P., Identification of a novel TP53 germline mutation E285V in a rare case of paediatric adrenocortical carcinoma and choroid plexus carcinoma (2008) J. Med. Genet., 45, pp. 603-606
Ikezoe, T., Miller, C.W., Kawano, S., Heaney, A., Williamson, E.A., Hisatake, J., Green, E., Koeffler, H.P., Mutational analysis of the peroxisome proliferator-activated receptor gamma gene in human malignancies (2001) Cancer Res., 61, pp. 5307-5310
Tsai, Y.S., Kim, H.J., Takahashi, N., Kim, H.S., Hagaman, J.R., Kim, J.K., Maeda, N., Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPARγ (2004) J. Clin. Invest, 114, pp. 163-175
Meredith, D., Panchatcharam, M., Miriyala, S., Tsai, Y.S., Morris, A.J., Maeda, N., Stouffer, G.A., Smyth, S.S., Dominant-negative loss of PPARγ function enhances smooth muscle cell proliferation, migration, and vascular remodeling (2009) Arterioscler. Thromb. Vasc. Biol., 29, pp. 465-471
Francis, G. A., Fayard, E., Picard, F., Auwerx, J., Nuclear receptors and the control of metabolism (2003) Ann. Rev. Physiol., 65, pp. 261-31
Spiegelman, B. M., PPAR: adipogenic regulator and thiazolidinedione receptor (1998) Diabetes, 47, pp. 507-514
Feige, J. N., Gelman, L., Michalik, L., Desvergne, B., Wahli, W., From molecular action to physiological outputs: peroxisome proliferator-activated receptors are nuclear receptors at the crossroads of key cellular functions (2006) Prog. Lipid Res., 45, pp. 120-159
Willson, T. M., Lambert, M. H., Kliewer, S. A., Peroxisome proliferator-activated receptor and metabolic disease (2001) Annu. Rev. Biochem., 70, pp. 341-367
Savage, D. B., Tan, G. D., Acerini, C. L., Jebb, S. A., Agostini, M., Gurnell, M., Williams, R. L., O'Rahilly, S., Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator-activated receptor (2003) Diabetes, 52, pp. 910-917
Peverali, F. A., Ramqvist, T., Saffrich, R., Pepperkok, R., Barone, M. V., Philipson, L., Regulation of G1 progression by E2A and Id helix-loop-helix proteins (1994) EMBO J., 13, pp. 4291-4301
Barone, M. V., Courtneidge, S. A., Myc but not Fos rescue of PDGF signaling block caused by kinase-inactive Src (1995) Nature, 378, pp. 509-512
Yeh, J. J., Marsh, D. J., Zedenius, J., Dwight, T., Delbridge, L., Robinson, B. G., Eng, C., Fine-structure deletion mapping of 10q22-24 identifies regions of loss of heterozygosity and suggests that sporadic follicular thyroid adenomas and follicular thyroid carcinomas develop along distinct neoplastic pathways (1999) Genes Chromosomes Cancer, 26, pp. 322-328
Kinzler, K. W., Vogelstein, B., Lessons from hereditary colorectal cancer (1996) Cell, 87, pp. 159-170
Gupta, R. A., Sarraf, P., Mueller, E., Brockman, J. A., Prusakiewicz, J. J., Eng, C., Willson, T. M., DuBois, R. N., Peroxisome proliferator-activated receptor mediated differentiation: a mutation in colon cancer cells reveals divergent and cell type-specific mechanisms (2003) J. Biol. Chem., 278, pp. 22669-22677
Girnun, G. D., Smith, W. M., Drori, S., Sarraf, P., Mueller, E., Eng, C., Nambiar, P., Spiegelman, B. M., APC-dependent suppression of colon carcinogenesis by PPAR (2002) Proc. Natl. Acad. Sci. U. S. A., 99, pp. 13771-13776
Teresi, R. E., Shaiu, C. W., Chen, C. S., Chatterjee, V. K., Waite, K. A., Eng, C., Increased PTEN expression due to transcriptional activation of PPAR by lovastatin and rosiglitazone (2006) Int. J. Cancer, 118, pp. 2390-2398
Annicotte, J. S., Iankova, I., Miard, S., Fritz, V., Sarruf, D., Abella, A., Berthe, M. L., Iborra, F., Peroxisome proliferator-activated receptor regulates E-cadherin expression and inhibits growth and invasion of prostate cancer (2006) Mol. Cell. Biol., 26, pp. 7561-7574
Iatropoulos, M. J., Williams, G. M., Proliferation markers (1996) Exp. Toxicol. Pathol., 48, pp. 175-181
Platt, A. M., Mowat, A. M., Mucosal macrophages and the regulation of immune responses in the intestine (2008) Immunol. Lett., 119, pp. 22-31
Gampe, R. T., Montana, V. G., Lambert, M. H., Miller, A. B., Bledsoe, R. K., Milburn, M. V., Kliever, S. A., Xu, E. H., Asymmetry in the PPAR /RXR crystal structure reveals the molecular basis of heterodimerization among nuclear receptors (2000) Mol. Cell, 5, pp. 545-555
Petersen, M. T., Jonson, P. H., Petersen, S. B., Amino acid neighbours and detailed conformational analysis of cysteines in proteins (1999) Protein Eng., 12, pp. 535-548
Kraulis, P. J., MOLSCRIPT: a program to produce both detailed and schematic plots of protein structures (1991) J. Appl. Crystallogr., 24, pp. 946-950
Tsai, Y. S., Kim, H. J., Takahashi, N., Kim, H. S., Hagaman, J. R., Kim, J. K., Maeda, N., Hypertension and abnormal fat distribution but not insulin resistance in mice with P465L PPAR (2004) J. Clin. Invest, 114, pp. 163-175
We report a novel PPARG germline mutation in a patient affected by colorectal cancer that replaces serine 289 with cysteine in the mature protein (S289C). The mutant has impaired transactivation potential and acts as dominant negative to the wild type receptor. In addition, it no longer restrains cell proliferation both in vitro and in vivo. Interestingly, the S289C mutant poorly activates target genes and interferes with the inflammatory pathway in tumor tissues and proximal normal mucosa. Consistently, only mutation carriers exhibit colonic lesions that can evolve to dysplastic polyps. The proband presented also dyslipidemia, hypertension and overweight, not associated to type 2 diabetes; of note, family members tested positive for the mutation and display only a dyslipidemic profile at variable penetrance with other biochemical parameters in the normal range. Finally, superimposing the mutation to the crystal structure of the ligand binding domain, the new Cys289 becomes so closely positioned to Cys285 to form an S-S bridge. This would reduce the depth of the ligand binding pocket and impede agonist positioning, explaining the biological effects and subcellular distribution of the mutant protein. This is the first PPARG germline mutation associated with dyslipidemia and colonic polyp formation that can progress to full-blown adenocarcinoma. © 2010 Elsevier B.V.
Nessun risultato. |
| 18-F-FDG PET, PET/CT AND MDCT IN LOCALLY ADVANCED COLORECTAL CANCER (dominio pubblico) (126 visite) |
Vai a fine pagina Versione per copia e incolla facile Esporta tutto in BibTeX Esporta tutto in EndNote
Ala U, Manco M, Mandili G, Tolosano E, Novelli F, Provero P, Altruda F, Fagoonee S
* Proteomics-Based Evidence for a Pro-Oncogenic Role of ESRP1 in Human Colorectal Cancer Cells (16 visite)
Int J Mol Sc (ISSN: 1422-0067linking, 1661-6596, 1422-0067electronic), 2020 Jan 16; 21 (2 ): N/D-N/D.
Impact Factor: 2.598
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Stanzione A, Guarino S, Romeo V, Ugga L, Romano F, Storto G, Maurea S, Brunetti A
* Colorectal cancer: Parametric evaluation of morphological, functional and molecular tomographic imaging (37 visite)
World J Gastroentero (ISSN: 1007-9327linking, 2219-2840), 2019 Sep 21; 25 (35 ): 5233-5256.
Impact Factor: 2.24
Dettagli Esporta in BibTeX Esporta in EndNote
Barresi V, Valenti G, Spampinato G, Musso N, Castorina S, Rizzarelli E, Condorelli DF
* Transcriptome analysis reveals an altered expression profile of zinc transporters in colorectal cancer (105 visite)
J Cell Biochem (ISSN: 0730-2312linking), 2018 Dec; 119(12): 9707-9719.
Impact Factor: 2.959
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Simonetti I, Tarotto L, Trovato P, Mainolfi CG, Salvatore B, Pace L
* 18-F-FDG PET, PET/CT AND MDCT IN LOCALLY ADVANCED COLORECTAL CANCER (104 visite) (PDF 126 visite)
Int J Of Current Res, 2017 Jul; 9: 53960-53964.
Impact Factor: 7.086
Dettagli Esporta in BibTeX Esporta in EndNote
Fagoonee S, Picco G, Orso F, Arrigoni A, Longo DL, Forni M, Scarfo I, Cassenti A, Piva R, Cassoni P, Silengo L, Tolosano E, Aime S, Taverna D, Pandolfi PP, Brancaccio M, Medico E, Altruda F
* The RNA-binding protein ESRP1 promotes human colorectal cancer progression (217 visite)
Oncotarget (ISSN: 1949-2553electronic, 1949-2553linking), 2017 Feb 07; 8(6): 10007-10024.
Impact Factor: 5.168
Dettagli Esporta in BibTeX Esporta in EndNote
Caviglia GP, Cabianca L, Fagoonee S, Gili FM
* Colorectal cancer detection in an asymptomatic population: Fecal immunochemical test for hemoglobin vs. Fecal M2-type pyruvate kinase (195 visite)
Biochem Medica (ISSN: 1330-0962), 2016; 26(1): 114-120.
Impact Factor: 2.934
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Romano F, Pizzuti L, Segreto S, Storto G, Mannelli L, Imbriaco M, Camera L, Maurea S
* Non-invasive diagnostic imaging of colorectal liver metastases (180 visite)
World J Radiol (ISSN: 1949-8470electronic, 1949-8470linking), 2015 Jul 28; 7(7): 157-169.
Impact Factor: 0.567
Dettagli Esporta in BibTeX Esporta in EndNote
Greco A, D'Alterio C, Auletta L, Albanese S, Napolitano M, Portella L, Santagata S, Ierano C, Brunetti A, Scala S, Zannetti A
* Longitudinal evaluation with High Frequency Ultrasound imaging of response to CXCR4 new cyclic peptide antagonist with conventional chemotherapy in colorectal cancer mice model (264 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 1619-7070print), 2015; 42: S425-S425.
Impact Factor: 5.537
Dettagli Esporta in BibTeX Esporta in EndNote
Cicatiello V, Apicella I, Tudisco L, Tarallo V, Formisano L, Sandomenico A, Kim Y, Bastos-Carvalho A, Orlandi A, Ambati J, Ruvo M, Bianco R, de Falco S
* Powerful anti-tumor and anti-angiogenic activity of a new anti-vascular endothelial growth factor receptor 1 peptide in colorectal cancer models (243 visite)
Oncotarget (ISSN: 1949-2553, 1949-2553electronic, 1949-2553linking), 2015; 6(12): 10563-10576.
Impact Factor: 5.008
Dettagli Esporta in BibTeX Esporta in EndNote
Napolitano S, Troiani T, Morgillo F, Ciardiello F, Belli G, Cioffi L, Sirignano C, Martinelli E
* Predictive Biomarkers To Anti-Egfr Inhibitors Treatment In The Management Of Metastatic Colorectal Cancer (134 visite)
Journal Of Carcinogenesis & Mutagenesis, 2014; N/D: 2157-2518.
Impact Factor: 3.445
Dettagli Esporta in BibTeX Esporta in EndNote
Vitale M, Luongo D, Naviglio D, Bozzetto L, Mirabella M, Rivieccio AM, Giacco A, Rivellese AA
* Trans fatty acids consumption in type 1 diabetic patients: evaluation by dietary records and measurement in serum phospholipids (255 visite)
Acta Diabetol (ISSN: 0940-5429, 1432-5233electronic), 2013 Aug; 50(4): 651-654.
Impact Factor: 3.679
Dettagli Esporta in BibTeX Esporta in EndNote
Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, Molinari L, Mainenti P, Cammarota A, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (177 visite)
International Journal Of Colorectal Disease (ISSN: 0179-1958, 0179-1958linking), 2013 Jul 12; 28(12): 1699-1705.
Impact Factor: 2.415
Dettagli Esporta in BibTeX Esporta in EndNote
Rosa R, Marciano R, Malapelle U, Formisano L, Nappi L, D'Amato C, D'Amato V, Damiano V, Marf G, Del Vecchio S, Zannetti A, Greco A, De Stefano A, Carlomagno C, Veneziani BM, Troncone G, De Placido S, Bianco R
* Sphingosine Kinase 1 Overexpression Contributes to Cetuximab Resistance in Human Colorectal Cancer Models (309 visite)
Clin Cancer Res (ISSN: 1078-0432, 1078-0432linking, 1078-0432print), 2013 Jan 1; 19(1): 138-147.
Impact Factor: 8.193
Dettagli Esporta in BibTeX Esporta in EndNote
Perrone-Filardi P, Musella F, Savarese G, Cecere M, Marciano C, Scala O, Rengo G, Dellegrottaglie S, Cuocolo A, Leosco D
* Coronary computed tomography: current role and future perspectives for cardiovascular risk stratification (241 visite)
Eur Heart J-Card Img (ISSN: 2047-2412, 2047-2404, 2047-2412electronic), 2012 Jun; 13(6): 453-458.
Impact Factor: 3.669
Dettagli Esporta in BibTeX Esporta in EndNote
Bucci M, Cigliano L, Vellecco V, D'Andrea LD, Ziaco B, Rossi A, Sautebin L, Carlucci A, Abrescia P, Pedone C, Ianaro A, Cirino G
* Apolipoprotein A-I (ApoA-I) mimetic peptide P2a by restoring cholesterol esterification unmasks ApoA-I anti-inflammatory endogenous activity in vivo (238 visite)
J Pharmacol Exp Ther (ISSN: 1521-0103, 0022-3565), 2012 Mar; 340(3): 716-722.
Impact Factor: 3.891
Dettagli Esporta in BibTeX Esporta in EndNote
Santulli G, Lombardi A, Sorriento D, Anastasio A, Del Giudice C, Formisano P, Béguinot F, Trimarco B, Miele C, Iaccarino G
* Age-related impairment in insulin release: The essential role of β 2-adrenergic receptor (282 visite)
Diabetesdiabetes (ISSN: 0012-1797), 2012; 61(3): 692-701.
Impact Factor: 7.895
Dettagli Esporta in BibTeX Esporta in EndNote
Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, Maione AS, Condorelli G, Puca A, Trimarco B, Illario M, Iaccarino G
* CaMK4 gene deletion induces hypertension (212 visite)
J Am Heart Assoc Journal Of The American Heart Association (ISSN: 2047-9980), 2012; 1(4): N/D-N/D.
Impact Factor: 2.882
Dettagli Esporta in BibTeX Esporta in EndNote
Acampa W, Di Taranto MD, Morgante A, Salvatore B, Evangelista L, Ricci F, Costanzo P, De Sisto E, Filardi PP, Petretta M, Fortunato G, Cuocolo A
* C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging (205 visite)
Scand J Clin Lab Invest (ISSN: 0036-5513, 1502-7686), 2011 May; 71(3): 179-184.
Impact Factor: 1.156
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Iodice D, Segreto S, Storto G, Magliulo M, De Palma GD, Salvatore M, Pace L
* Colorectal cancer and 18FDG-PET/CT: what about adding the T to the N parameter in loco-regional staging? (170 visite)
World J Gastroentero (ISSN: 2219-2840, 1007-9327, 1007-9327linking), 2011 Mar 21; 17(11): 1427-1433.
Impact Factor: 2.471
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Mancini M, Mainolfi C, Camera L, Maurea S, Manchia A, Tanga M, Persico F, Addeo P, D'Antonio D, Speranza A, Bucci L, Persico G, Pace L, Salvatore M
* Detection of colo-rectal liver metastases: Prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1. 5 Tesla MR with extracellular and reticulo-endothelial cell specific contrast agents (211 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2010 Oct; 35(5): 511-521.
Impact Factor: 1.95
Dettagli Esporta in BibTeX Esporta in EndNote
Giacco R, Clemente G, Cipriano D, Luongo D, Viscovo D, Patti L, Di Marino L, Giacco A, Naviglio D, Bianchi MA, Ciati R, Brighenti F, Rivellese AA, Riccardi G
* Effects of the regular consumption of wholemeal wheat foods on cardiovascular risk factors in healthy people (247 visite)
Nutrition (ISSN: 0939-4753, 1590-3729electronic), 2010 Mar; 20(3): 186-194.
Impact Factor: 3.438
Dettagli Esporta in BibTeX Esporta in EndNote
Giacomobono S, Capacchione D, Lancellotti M, Nardelli A, Gallicchio R, Improta G, Nappi A, Cammarota A, Di Leo A, Pace L, Storto G
* F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer (146 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2009 Sep; 36: N/D-N/D.
Impact Factor: 4.531
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Nicolai E, Salvatore M
* [18F]FDG-PET-CT for early monitoring of tumor response: When and why (238 visite)
Q J Nucl Med Mol Im (ISSN: 1824-4785, 1824-4478, 1824-4785linking), 2009 Apr; 53(2): 167-180.
Impact Factor: 1.724
Dettagli Esporta in BibTeX Esporta in EndNote
Cigliano L, D'Andrea LD, Maresca B, Serino M, Carlucci A, Salvatore A, Spagnuolo MS, Scigliuolo G, Pedone C, Abrescia P
* Relevance of the amino acid conversions L144R (Zaragoza) and L159P (Zavalla) in the apolipoprotein A-I binding site for haptoglobin (230 visite)
Biol Chem Biological Chemistry (ISSN: 1431-6730, 1437-4315), 2008 Nov; 389(11): 1421-1426.
Impact Factor: 3.035
Dettagli Esporta in BibTeX Esporta in EndNote
Salvatore B, Simeone R, Fonti R, Marciano R, Bianco R, Damiano V, Tortora G, Pace L, Del Vecchio S, Salvatore M
* 18F-FDG PET/CT in the assessment of early response to chemotherapy and molecularly targeted agents in metastatic colorectal cancer (160 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2008 Oct; 35: N/D-N/D.
Impact Factor: 4.532
Dettagli Esporta in BibTeX Esporta in EndNote
Vettor R, Granzotto M, De Stefani D, Trevellin E, Rossato M, Farina MG, Milan G, Pilon C, Nigro A, Federspil G, Vigneri R, Vitiello L, Rizzuto R, Baratta R, Frittitta L
* Loss-of-function mutation of the GPR40 gene associates with abnormal stimulated insulin secretion by acting on intracellular calcium mobilization (177 visite)
Journal Of Clinical Endocrinology & Metabolism (ISSN: 0021-972x), 2008 Sep; 93(9): 3541-3550.
Impact Factor: 6.325
Dettagli Esporta in BibTeX Esporta in EndNote
De Simone G, Di Fiore A, Supuran CT
* Are carbonic anhydrase inhibitors suitable for obtaining antiobesity drugs? (211 visite)
Curr Pharm Des Current Pharmaceutical Design (ISSN: 1381-6128, 1873-4286), 2008 Mar; 14(7): 655-660.
Impact Factor: 4.399
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Cirillo LC, Camera L, Persico F, Cantalupo T, Pace L, De Palma GD, Persico G, Salvatore M
* Accuracy of single phase contrast enhanced multidetector CT colonography in the preoperative staging of colo-rectal cancer (184 visite)
Eur J Radiol (ISSN: 0720-048x), 2006 Dec; 60(3): 453-459.
Impact Factor: 1.332
Dettagli Esporta in BibTeX Esporta in EndNote
Caprio MG, Cantalupo T, Mainenti PP, Mainolfi CG, Varrone A, Salvatore B, Persico F, D'Antonio D, Pace L, Salvatore M
* 18F-fdg pet, pet/ct and ce-mdct in locally advanced colorectal cancer (184 visite) (PDF 126 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Storto G, Mainenti PP, Varrone A, Mainolfi C, Salvatore B, Caprio MG, Cella L, Soricelli A, Pace L, Salvatore M
* Role of FDG-PET/CT in the staging of colorectal cancer (179 visite)
Eur J Nucl Med (ISSN: 1619-7070, 1619-7089, 0340-6997), 2006 Sep; 33: N/D-N/D.
Impact Factor: 4.041
Dettagli Esporta in BibTeX Esporta in EndNote
Palmieri V, Storto G, Arezzi E, Pellegrino T, Mancini M, Di Minno G, Ferrara AL, Cuocolo A, Celentano A
* Relations of left ventricular mass and systolic function to endothelial function and coronary flow reserve in healthy, new discovered hypertensive subjects (182 visite)
J Hum Hypertens (ISSN: 0950-9240), 2005 Dec; 19(12): 941-950.
Impact Factor: 2.405
Dettagli Esporta in BibTeX Esporta in EndNote
Colao A, Di Somma C, Cuocolo A, Spinelli L, Acampa W, Spiezia S, Rota F, Savanelli MC, Lombardi G
* Does a gender-related effect of growth hormone (GH) replacement exist on cardiovascular risk factors, cardiac morphology, and performance and atherosclerosis? Results of a two-year open, prospective study in young adult men and women with severe GH deficiency (231 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2005 Sep; 90(9): 5146-5155.
Impact Factor: 6.02
Dettagli Esporta in BibTeX Esporta in EndNote
Foti D, Chiefari E, Fedele M, Iuliano R, Brunetti L, Paonessa F, Manfioletti G, Barbetti F, Brunetti A, Croce CM, Fusco A, Brunetti A
* Lack of the architectural factor HMGA1 causes insulin resistance and diabetes in humans and mice (225 visite)
Nat Med (ISSN: 1078-8956, 0034-7264), 2005 Jul; 11(7): 765-773.
Impact Factor: 28.878
Dettagli Esporta in BibTeX Esporta in EndNote
Mainenti PP, Romano M, Imbriaco M, Camera L, Pace L, D'Antonio D, Bucci L, Galloro G, Salvatore M
* Added value of CT colonography after a positive conventional colonoscopy: Impact on treatment strategy (219 visite)
Abdom Imaging (ISSN: 0942-8925, 1432-0509), 2005 Jan; 30(1): 42-47.
Impact Factor: 1.034
Dettagli Esporta in BibTeX Esporta in EndNote
Giacco R, Clemente G, Luongo D, Lasorella G, Fiume I, Brouns F, Bornet F, Patti L, Cipriano P, Rivellese AA, Riccardi G
* Effects of short-chain fructo-oligosaccharides on glucose and lipid metabolism in mild hypercholesterolaemic individuals (238 visite)
Clin Nutr (ISSN: 0261-5614, 0261-5614linking), 2004 Jun; 23(3): 331-340.
Impact Factor: 2.019
Dettagli Esporta in BibTeX Esporta in EndNote
Pauciullo P, Giannino A, De Michele M, Gentile M, Liguori R, Argiriou A, Carlotto A, Faccenda F, Mancini M, Bond MG, De Simone V, Rubba P
* Increased carotid artery intima-media thickness is associated with a novel mutation of low-density lipoprotein receptor independently of major cardiovascular risk factors (306 visite)
Metab Clin Exp (ISSN: 0026-0495, 1532-8600), 2003; 52(11): 1433-1438.
Impact Factor: 2.013
Dettagli Esporta in BibTeX Esporta in EndNote
Colao A, Di Somma C, Pivonello R, Cuocolo A, Spinelli L, Bonaduce D, Salvatore M, Lombardi G
* The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: A 12-month prospective study (193 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2002 Mar; 87(3): 1088-1093.
Impact Factor: 5.199
Dettagli Esporta in BibTeX Esporta in EndNote
Colao A, Di Somma C, Cuocolo A, Spinelli L, Tedesco N, Pivonello R, Bonaduce D, Salvatore M, Lombardi G
* Improved cardiovascular risk factors and cardiac performance after 12 months of growth hormone (GH) replacement in young adult patients, with GH deficiency (189 visite)
J Clin Endocrinol Metab (ISSN: 0021-972x), 2001 May; 86(5): 1874-1881.
Impact Factor: 5.16
Dettagli Esporta in BibTeX Esporta in EndNote
Renda A, Iovino F, Capasso L, Ricciardelli L, Tammaro V, Acampa W
Radioimmunoguided surgery in colorectal cancer: A 6-year experience with four different technical solutions (172 visite)
Semin Surg Oncol Wiley Liss Inc (ISSN: 8756-0437), 1998 Dec; 15(4): 226-230.
Impact Factor: 1.045
Dettagli Esporta in BibTeX Esporta in EndNote
Marotta T, Ferrara LA, Di Marino L, Mancini M, Annuzzi G, Russo O, D'Orta G, Lucarelli C, Rossi F
Factors affecting lipoprotein lipase in hypertensive patients (177 visite)
Metab Clin Exp (ISSN: 0026-0495, 1532-8600), 1995 Jun; 44(6): 712-718.
Impact Factor: 1.681
Dettagli Esporta in BibTeX Esporta in EndNote
Alfano B, Coucourde F, Malgieri F, Ragozzino A
PET/CT and radiotherapy (865 visite)
Q J Nucl Med Mol Imaging, 1980 Oct; 50(1): 4-14.
Impact Factor: 0
Dettagli Esporta in BibTeX Esporta in EndNote
41 Records (37 escludendo Abstract e Conferenze).
Impact factor totale: 168.595 (151.45 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 150.995 (132.65 escludendo Abstract e Conferenze).
Impact factor totale: 168.595 (151.45 escludendo Abstract e Conferenze).
Impact factor a 5 anni totale: 150.995 (132.65 escludendo Abstract e Conferenze).
Esporta in BibTeX Esporta in EndNote
Ultima modifica di Marco Comerci in data Wednesday 26 March 2014, 9:29:57
192 visite. Ultima visita in data Monday 30 March 2020, 18:29:08
ibb.cnr.it